Site Map     Privacy & Terms

PACE Technology

Clinical Studies

Scientific Literature




The dermaPACE™ device is currently available only to physicians and patients involved in an Investigational Device Exemption clinical trial. It is not for sale in the United States.

For further information regarding dermaPACE please visit:
or for more information on the trial
please visit:


The orthoPACE™ is CE marked for international markets for orthopedic and musculoskeletal indications, but is not currently approved for sale or distribution in the United States.


The OssaTron is the first and only Extracorporeal Shock Wave Technology (ESWT) system approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple orthopaedic conditions which have failed to respond to conservative treatment.

Copyright © 2006-2010 SANUWAVE, Inc. All Rights Reserved. OssaTron, EvoTron, VersaTron, dermaPACE, OrthoTripsy and “Healing Today. Curing Tomorrow.” are all registered trademarks of SANUWAVE.